|
1
|
GLOBOCAN 2012. 11–June. 2017http://globocan.iarc.fr/
|
|
2
|
CANCERSTATISTICSINJAPAN'15. 11–June.
2017http://ganjoho.jp/en/professional/statistics/brochure/2015_en.html
|
|
3
|
Böckelman C, Engelmann BE, Kaprio T,
Hansen TF and Glimelius B: Risk of recurrence in patients with
colon cancer stage II and III: A systematic review and
meta-analysis of recent literature. Acta Oncol. 54:5–16. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Verhoeff SR, van Erning FN, Lemmens VE, de
Wilt JH and Pruijt JF: Adjuvant chemotherapy is not associated with
improved survival for all high-risk factors in stage II colon
cancer. Int J Cancer. 139:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schneikert J and Behrens J: The canonical
Wnt signalling pathway and its APC partner in colon cancer
development. Gut. 56:417–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barker N, van Es JH, Kuipers J, Kujala P,
van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H,
Peters PJ and Clevers H: Identification of stem cells in small
intestine and colon by marker gene Lgr5. Nature. 449:1003–1007.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barker N and Clevers H: Leucine-rich
repeat-containing G-protein-coupled receptors as markers of adult
stem cells. Gastroenterology. 138:1681–1696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirsch D, Barker N, McNeil N, Hu Y, Camps
J, McKinnon K, Clevers H, Ried T and Gaiser T: LGR5 positivity
defines stem-like cells in colorectal cancer. Carcinogenesis.
35:849–858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barker N, Ridgway RA, van Es JH, van de
Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR,
Sansom OJ and Clevers H: Crypt stem cells as the cells-of-origin of
intestinal cancer. Nature. 457:608–611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu S, Tamada K, Ni J, Vincenz C and Chen
L: Characterization of TNFRSF19, a novel member of the tumor
necrosis factor receptor superfamily. Genomics. 62:103–107. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fafilek B, Krausova M, Vojtechova M,
Pospichalova V, Tumova L, Sloncova E, Huranova M, Stancikova J,
Hlavata A, Svec J, et al: Troy, a tumor necrosis factor receptor
family member, interacts with lgr5 to inhibit wnt signaling in
intestinal stem cells. Gastroenterology. 144:381–391. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spanjaard RA, Whren KM, Graves C and
Bhawan J: Tumor necrosis factor receptor superfamily member TROY is
a novel melanoma biomarker and potential therapeutic target. Int J
Cancer. 120:1304–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paulino VM, Yang Z, Kloss J, Ennis MJ,
Armstrong BA, Loftus JC and Tran NL: TROY (TNFRSF19) is
overexpressed in advanced glial tumors and promotes glioblastoma
cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res. 8:1558–1567.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Loftus JC, Dhruv H, Tuncali S, Kloss J,
Yang Z, Schumacher CA, Cao B, Williams BO, Eschbacher JM and Ross
JT: TROY (TNFRSF19) promotes glioblastoma survival signaling and
therapeutic resistance. Mol Cancer Res. 11:865–874. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schön S, Flierman I, Ofner A, Stahringer
A, Holdt LM, Kolligs FT and Herbst A: β-catenin regulates NF-κB
activity via TNFRSF19 in colorectal cancer cells. Int J Cancer.
135:1800–1811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumours. 7th. Hoboken
Wiley-Blackwell; pp. 3362009
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H,
Kenetaka K, Asaka M and Hirohashi S: Overexpression of orphan
G-protein-coupled receptor, Gpr49, in human hepatocellular
carcinomas with beta-catenin mutations. Hepatology. 37:528–533.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tanese K, Fukuma M, Yamada T, Mori T,
Yoshikawa T, Watanabe W, Ishiko A, Amagai M, Nishikawa T and
Sakamoto M: G-protein-coupled receptor GPR49 is up-regulated in
basal cell carcinoma and promotes cell proliferation and tumor
formation. Am J Pathol. 173:835–843. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun B, Ye X, Li Y and Zhang W: Lgr5 is a
potential prognostic marker in patients with cervical carcinoma.
Int J Clin Exp Pathol. 8:1783–1789. 2015.PubMed/NCBI
|
|
23
|
Sun Y, Jia X and Wu X: High expressions of
Lgr5 and ALDH1 in primary epithelial ovarian cancer correlate with
advanced tumor stage and grade as well as poor prognosis of the
patients. Gynecol Obstet Invest. 20–Jun;2015.(Epub ahead of print).
View Article : Google Scholar
|
|
24
|
Takahashi H, Ishii H, Nishida N, Takemasa
I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Yamamoto H, Sekimoto
M, et al: Significance of Lgr5(+ve) cancer stem cells in the colon
and rectum. Ann Surg Oncol. 18:1166–1174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu XS, Xi HQ and Chen L: Lgr5 is a
potential marker of colorectal carcinoma stem cells that correlates
with patient survival. World J Surg Oncol. 10:2442012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saigusa S, Inoue Y, Tanaka K, Toiyama Y,
Kawamura M, Okugawa Y, Okigami M, Hiro J, Uchida K, Mohri Y and
Kusunoki M: Significant correlation between LKB1 and LGR5 gene
expression and the association with poor recurrence-free survival
in rectal cancer after preoperative chemoradiotherapy. J Cancer Res
Clin Oncol. 139:131–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu HC, Liu YS, Tseng KC, Hsu CL, Liang Y,
Yang TS, Chen JS, Tang RP, Chen SJ and Chen HC: Overexpression of
Lgr5 correlates with resistance to 5-FU-based chemotherapy in
colorectal cancer. Int J Colorectal Dis. 28:1535–1546. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barker N, Tan S and Clevers H: Lgr
proteins in epithelial stem cell biology. Development.
140:2484–2494. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dhruv HD, Roos A, Tomboc PJ, Tuncali S,
Chavez A, Mathews I, Berens ME, Loftus JC and Tran NL:
Propentofylline inhibits glioblastoma cell invasion and survival by
targeting the TROY signaling pathway. J Neurooncol. 126:397–404.
2016. View Article : Google Scholar : PubMed/NCBI
|
